1. Home
  2. UA vs OGN Comparison

UA vs OGN Comparison

Compare UA & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UA
  • OGN
  • Stock Information
  • Founded
  • UA 1996
  • OGN 1923
  • Country
  • UA United States
  • OGN United States
  • Employees
  • UA N/A
  • OGN N/A
  • Industry
  • UA Apparel
  • OGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • UA Consumer Discretionary
  • OGN Health Care
  • Exchange
  • UA Nasdaq
  • OGN Nasdaq
  • Market Cap
  • UA 2.6B
  • OGN 2.5B
  • IPO Year
  • UA N/A
  • OGN N/A
  • Fundamental
  • Price
  • UA $6.56
  • OGN $9.82
  • Analyst Decision
  • UA
  • OGN Hold
  • Analyst Count
  • UA 0
  • OGN 4
  • Target Price
  • UA N/A
  • OGN $18.00
  • AVG Volume (30 Days)
  • UA 2.7M
  • OGN 3.5M
  • Earning Date
  • UA 08-07-2025
  • OGN 08-05-2025
  • Dividend Yield
  • UA N/A
  • OGN 0.81%
  • EPS Growth
  • UA N/A
  • OGN N/A
  • EPS
  • UA N/A
  • OGN 2.88
  • Revenue
  • UA $5,164,310,000.00
  • OGN $6,294,000,000.00
  • Revenue This Year
  • UA N/A
  • OGN N/A
  • Revenue Next Year
  • UA $2.72
  • OGN $1.11
  • P/E Ratio
  • UA N/A
  • OGN $3.42
  • Revenue Growth
  • UA N/A
  • OGN N/A
  • 52 Week Low
  • UA $4.62
  • OGN $8.01
  • 52 Week High
  • UA $10.62
  • OGN $23.10
  • Technical
  • Relative Strength Index (RSI)
  • UA 52.83
  • OGN 48.62
  • Support Level
  • UA $6.54
  • OGN $9.74
  • Resistance Level
  • UA $6.88
  • OGN $10.27
  • Average True Range (ATR)
  • UA 0.24
  • OGN 0.36
  • MACD
  • UA -0.02
  • OGN -0.00
  • Stochastic Oscillator
  • UA 35.62
  • OGN 29.78

About UA Under Armour Inc. Class C

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: